Roots Analysis is pleased to announce the publication of its recent study, titled, “Biologics Fill / Finish Services Market, 2019-2030.” The report features an extensive study on the contract service providers offering drug product manufacturing services within the biopharmaceutical industry. One of the key objectives of this report was to estimate the current market […]
The contract fill / finish services market Read More »
In the past few years, there has been a significant surge in the demand for recombinant proteins and cellular systems for biomedical research, diagnostics and different therapies. In order to support the large- scale production and manufacturing of such cell- based products, there is an imperative need for the efficient development of high- quality stable
CHALLENGES AND OPPORTUNITIES FOR CELL LINE DEVELOPMENT Read More »
Roots Analysis has announced the addition of “Exosomes Development and Manufacturing Services Market, 2022-2035” report to its list of offerings. Despite the growing interest in exosomes-based therapeutics and diagnostics, the development of exosomes has been restricted owing to the multiple challenges in their manufacturing, such as heterogeneity of exosomes, optimization of exosome isolation, purification
Roots Analysis has announced the addition of “Gene Therapy Market (4th Edition), 2020-2030” report to its list of offerings. Success of approved gene therapies has resulted in a surge in interest of biopharmaceutical developers in this rapidly evolving domain. Presently, the ability of gene therapies to treat diverse disease indications is considered among the
Roots Analysis has announced the addition of “Global Psychedelic Therapeutics Market, 2020-2030” report to its list of offerings. The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade. It features an in-depth analysis, highlighting the capabilities of various
Roots Analysis is pleased to announce the publication of its recent study, titled, “Biologics Fill / Finish Services Market, 2019-2030.” The report features an extensive study on the contract service providers offering drug product manufacturing services within the biopharmaceutical industry. One of the key objectives of this report was to estimate the current market
In the past few years, there has been a significant surge in the demand for recombinant proteins and cellular systems for biomedical research, diagnostics and different therapies. In order to support the large- scale production and manufacturing of such cell- based products, there is an imperative need for the efficient development of high- quality stable
Roots Analysis is pleased to announce the publication of its recent study, titled, “HPAPI and Cytotoxic Drugs Manufacturing (3rd Edition) 2020-2030.” The report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of HPAPIs and cytotoxic drugs. The study also features a detailed analysis of the
Roots Analysis is pleased to announce the publication of its recent study, titled “Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030” report to its list of offerings. The report provides a detailed study on the current market landscape and future potential of biologics designed for subcutaneous administration. In addition, the study provides
The subcutaneous biologic drugs and affiliated technologies market Read More »
Roots Analysis has announced the addition of “Biopharmaceutical Excipient Market” report to its list of offerings Owing to the highly complex and capital-intensive manufacturing processes of biopharmaceutical excipients, many contemporary biologic developers prefer to rely on CMOs for the supply of GMP grade excipients. In order to cater to the growing demand for biopharmaceutical
The biopharmaceutical excipient manufacturing market Read More »
